357 related articles for article (PubMed ID: 28428247)
1. Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss.
Press ER; Shao Q; Kelly JJ; Chin K; Alaga A; Laird DW
J Biol Chem; 2017 Jun; 292(23):9721-9732. PubMed ID: 28428247
[TBL] [Abstract][Full Text] [Related]
2. Mutations in Cx30 that are linked to skin disease and non-syndromic hearing loss exhibit several distinct cellular pathologies.
Berger AC; Kelly JJ; Lajoie P; Shao Q; Laird DW
J Cell Sci; 2014 Apr; 127(Pt 8):1751-64. PubMed ID: 24522190
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30.
Marziano NK; Casalotti SO; Portelli AE; Becker DL; Forge A
Hum Mol Genet; 2003 Apr; 12(8):805-12. PubMed ID: 12668604
[TBL] [Abstract][Full Text] [Related]
4. Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30.
Yum SW; Zhang J; Scherer SS
Neurobiol Dis; 2010 May; 38(2):226-36. PubMed ID: 20096356
[TBL] [Abstract][Full Text] [Related]
5.
Beach R; Abitbol JM; Allman BL; Esseltine JL; Shao Q; Laird DW
Front Cell Dev Biol; 2020; 8():215. PubMed ID: 32300592
[No Abstract] [Full Text] [Related]
6. Connexin26 Mutations Causing Palmoplantar Keratoderma and Deafness Interact with Connexin43, Modifying Gap Junction and Hemichannel Properties.
Shuja Z; Li L; Gupta S; Meşe G; White TW
J Invest Dermatol; 2016 Jan; 136(1):225-235. PubMed ID: 26763442
[TBL] [Abstract][Full Text] [Related]
7. Transport and function of cx26 mutants involved in skin and deafness disorders.
Thomas T; Aasen T; Hodgins M; Laird DW
Cell Commun Adhes; 2003; 10(4-6):353-8. PubMed ID: 14681041
[TBL] [Abstract][Full Text] [Related]
8. Dominant Cx26 mutants associated with hearing loss have dominant-negative effects on wild type Cx26.
Zhang J; Scherer SS; Yum SW
Mol Cell Neurosci; 2011 Jun; 47(2):71-8. PubMed ID: 21040787
[TBL] [Abstract][Full Text] [Related]
9. Analysis of trafficking, stability and function of human connexin 26 gap junction channels with deafness-causing mutations in the fourth transmembrane helix.
Ambrosi C; Walker AE; Depriest AD; Cone AC; Lu C; Badger J; Skerrett IM; Sosinsky GE
PLoS One; 2013; 8(8):e70916. PubMed ID: 23967136
[TBL] [Abstract][Full Text] [Related]
10. Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43.
García IE; Maripillán J; Jara O; Ceriani R; Palacios-Muñoz A; Ramachandran J; Olivero P; Perez-Acle T; González C; Sáez JC; Contreras JE; Martínez AD
J Invest Dermatol; 2015 May; 135(5):1338-1347. PubMed ID: 25625422
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of gap- and tight-junction mutations in Turkish families with autosomal-recessive non-syndromic hearing loss.
Uyguner O; Emiroglu M; Uzumcu A; Hafiz G; Ghanbari A; Baserer N; Yuksel-Apak M; Wollnik B
Clin Genet; 2003 Jul; 64(1):65-9. PubMed ID: 12791041
[TBL] [Abstract][Full Text] [Related]
12. A deafness mechanism of digenic Cx26 (GJB2) and Cx30 (GJB6) mutations: Reduction of endocochlear potential by impairment of heterogeneous gap junctional function in the cochlear lateral wall.
Mei L; Chen J; Zong L; Zhu Y; Liang C; Jones RO; Zhao HB
Neurobiol Dis; 2017 Dec; 108():195-203. PubMed ID: 28823936
[TBL] [Abstract][Full Text] [Related]
13. Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss.
Choi SY; Park HJ; Lee KY; Dinh EH; Chang Q; Ahmad S; Lee SH; Bok J; Lin X; Kim UK
Hum Mutat; 2009 Jul; 30(7):E716-27. PubMed ID: 19384972
[TBL] [Abstract][Full Text] [Related]
14. The connexin 30 A88V mutant reduces cochlear gap junction expression and confers long-term protection against hearing loss.
Kelly JJ; Abitbol JM; Hulme S; Press ER; Laird DW; Allman BL
J Cell Sci; 2019 Jan; 132(2):. PubMed ID: 30559251
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of transcription factor Brn4 disrupts cochlear gap junction plaques in a model of DFN3 non-syndromic deafness.
Kidokoro Y; Karasawa K; Minowa O; Sugitani Y; Noda T; Ikeda K; Kamiya K
PLoS One; 2014; 9(9):e108216. PubMed ID: 25259580
[TBL] [Abstract][Full Text] [Related]
16. trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation.
Rouan F; White TW; Brown N; Taylor AM; Lucke TW; Paul DL; Munro CS; Uitto J; Hodgins MB; Richard G
J Cell Sci; 2001 Jun; 114(Pt 11):2105-13. PubMed ID: 11493646
[TBL] [Abstract][Full Text] [Related]
17. Intracellular domains of mouse connexin26 and -30 affect diffusional and electrical properties of gap junction channels.
Manthey D; Banach K; Desplantez T; Lee CG; Kozak CA; Traub O; Weingart R; Willecke K
J Membr Biol; 2001 May; 181(2):137-48. PubMed ID: 11420600
[TBL] [Abstract][Full Text] [Related]
18. Loss of function mutations of the GJB2 gene detected in patients with DFNB1-associated hearing impairment.
Palmada M; Schmalisch K; Böhmer C; Schug N; Pfister M; Lang F; Blin N
Neurobiol Dis; 2006 Apr; 22(1):112-8. PubMed ID: 16300957
[TBL] [Abstract][Full Text] [Related]
19. Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness.
Gerido DA; DeRosa AM; Richard G; White TW
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C337-45. PubMed ID: 17428836
[TBL] [Abstract][Full Text] [Related]
20. Conserved glycine at position 45 of major cochlear connexins constitutes a vital component of the Ca²⁺ sensor for gating of gap junction hemichannels.
Zhang Y; Hao H
Biochem Biophys Res Commun; 2013 Jul; 436(3):424-9. PubMed ID: 23756814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
